Prior chelation therapy
| Chelation regimen at screening . | No. (%) . |
|---|---|
| Deferoxamine | 6 (12) |
| Deferasirox | 11 (21) |
| Deferiprone | 15 (29) |
| Deferoxamine + deferiprone | 12 (22) |
| Deferoxamine + deferasirox | 3 (6) |
| Deferiprone + deferasirox | 1 (2) |
| No chelation therapy at screening* | 2 (4) |
| Naive to chelation therapy | 1 (2) |
| Chelation regimen at screening . | No. (%) . |
|---|---|
| Deferoxamine | 6 (12) |
| Deferasirox | 11 (21) |
| Deferiprone | 15 (29) |
| Deferoxamine + deferiprone | 12 (22) |
| Deferoxamine + deferasirox | 3 (6) |
| Deferiprone + deferasirox | 1 (2) |
| No chelation therapy at screening* | 2 (4) |
| Naive to chelation therapy | 1 (2) |
Two patients with side effects to deferasirox were off chelator for at least 30 days before screening.